KING RACHEL K. 1589712 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | 2023-06-10 | 4 | King Rachel K. | DIRECTOR | holding | 2200.0
|
0 | 0.25 | 0.0 | See Footnote F2 | Common Stock | NOVAVAX INC | NA | 86.31 (NVAX) | ||
| 2023-06-13 | 2023-06-10 | 2023-06-10 | 4 | King Rachel K. | DIRECTOR | acq | 3100.0 | 30.85 | 0.36 | 0.0 | Direct | Common Stock | NOVAVAX INC | code M | 10050.0 | 86.31 (NVAX) |
| 2023-10-03 | 2023-09-30 | 4 | King Rachel K. | DIRECTOR | holding | 92401.0 | 0 | 14.37 | 0.0 | By Trusts | Common Stock | GLYCOMIMETICS INC | NA | 64.32 (GLYC) | ||
| 2023-10-03 | 2023-09-30 | 4 | King Rachel K. | DIRECTOR | holding | 45741.0 | 0 | 7.11 | 0.0 | By Spouse | Common Stock | GLYCOMIMETICS INC | NA | 64.32 (GLYC) | ||
| 2023-10-03 | 2023-09-30 | 4 | King Rachel K. | DIRECTOR | holding | 7500.0 | 0 | 1.17 | 0.0 | By Rbk Llc | Common Stock | GLYCOMIMETICS INC | NA | 64.32 (GLYC) | ||
| 2023-10-03 | 2023-09-30 | 2023-09-30 | 4 | King Rachel K. | DIRECTOR | acq | 6667.0 | 1.31 | 1.04 | 1.5 | Direct | Common Stock | GLYCOMIMETICS INC | code A | 507622.0 | 64.32 (GLYC) |
| 2024-01-02 | 2023-12-29 | 2023-12-29 | 4 | King Rachel K. | DIRECTOR | acq | 4238.0 | 0.83 | 0.66 | 2.36 | Direct | Common Stock | GLYCOMIMETICS INC | code A | 511860.0 | 64.39 (GLYC) |
| 2024-01-02 | 2023-12-29 | 4 | King Rachel K. | DIRECTOR | holding | 92401.0 | 0 | 14.35 | 0.0 | By Trusts | Common Stock | GLYCOMIMETICS INC | NA | 64.39 (GLYC) | ||
| 2024-01-02 | 2023-12-29 | 4 | King Rachel K. | DIRECTOR | holding | 7500.0 | 0 | 1.16 | 0.0 | By Rbk Llc | Common Stock | GLYCOMIMETICS INC | NA | 64.39 (GLYC) | ||
| 2024-01-02 | 2023-12-29 | 4 | King Rachel K. | DIRECTOR | holding | 45741.0 | 0 | 7.1 | 0.0 | By Spouse | Common Stock | GLYCOMIMETICS INC | NA | 64.39 (GLYC) | ||
| 2024-04-02 | 2023-03-29 | 4 | King Rachel K. | DIRECTOR | holding | 90660.0 | 0 | 14.07 | 0.0 | By Trusts | Common Stock | GLYCOMIMETICS INC | NA | 64.45 (GLYC) | ||
| 2024-04-02 | 2023-03-29 | 4 | King Rachel K. | DIRECTOR | holding | 7500.0 | 0 | 1.16 | 0.0 | By Rbk Llc | Common Stock | GLYCOMIMETICS INC | NA | 64.45 (GLYC) | ||
| 2024-04-02 | 2023-03-29 | 4 | King Rachel K. | DIRECTOR | holding | 45741.0 | 0 | 7.1 | 0.0 | By Spouse | Common Stock | GLYCOMIMETICS INC | NA | 64.45 (GLYC) | ||
| 2024-04-02 | 2023-03-29 | 2024-03-29 | 4 | King Rachel K. | DIRECTOR | acq | 3334.0 | 0.65 | 0.52 | 3.0 | Direct | Common Stock | GLYCOMIMETICS INC | code A | 515194.0 | 64.45 (GLYC) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-22 | 2023-05-19 | 2023-05-19 | 4 | King Rachel K. | DIRECTOR | acq | 35000.0 | 100.0 | 5.45 | 1.98 | Direct | Stock Option (Right To Buy) | GLYCOMIMETICS INC | code A | 35000.0 | 64.25 (GLYC) |
| 2023-06-13 | 2023-06-10 | 2023-06-12 | 4 | King Rachel K. | DIRECTOR | acq | 6670.0 | 100.0 | 0.77 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code A | 6670.0 | 86.31 (NVAX) |
| 2023-06-13 | 2023-06-10 | 2023-06-10 | 4 | King Rachel K. | DIRECTOR | dsp | 3100.0 | 100.0 | 0.36 | 0.0 | Direct | Restricted Stock Units | NOVAVAX INC | code M | 0.0 | 86.31 (NVAX) |
| 2023-06-13 | 2023-06-10 | 2023-06-12 | 4 | King Rachel K. | DIRECTOR | acq | 7710.0 | 100.0 | 0.89 | 7.78 | Direct | Stock Option (Right To Buy) | NOVAVAX INC | code A | 7710.0 | 86.31 (NVAX) |
| 2024-05-01 | 2024-05-01 | 2024-05-01 | 4 | King Rachel K. | DIRECTOR | acq | 40000.0 | 100.0 | 6.21 | 1.62 | Direct | Stock Option (Right To Buy) | GLYCOMIMETICS INC | code A | 40000.0 | 64.45 (GLYC) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)